PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Shock. Author manuscript; available in PMC 2010 April 1.
Published in final edited form as:
PMCID: PMC2778022
NIHMSID: NIHMS114444

MODULATION OF THE BCL-2 FAMILY BLOCKS SEPSIS-INDUCED DEPLETION OF DENDRITIC CELLS AND MACROPHAGES

Abstract

This study examined the fate of dendritic cells (DCs) and macrophages (MΦ) in vivo in a murine model of sepsis. Wild-type, knockout, and transgenic mice were used to examine the role of Bcl-2 family members on the regulation of splenic DCs and MΦ survival. Bim knockout (Bim−/−) mice and mice overexpressing Bcl-2 in selected hematopoietic cells were used: (a) overexpression of Bcl-2 in all hematopoietic cells using a vav promoter (Vav–Bcl-2) and (b) overexpression of Bcl-2 in all MHC class I cells (H-2K–Bcl-2). Mice underwent sham surgery or cecal ligation and puncture, and absolute numbers of splenic DCs and MΦ were determined. Importantly, two distinct MΦ populations, that is, well-differentiated “mature” MΦ population and a less differentiated “immature,” “monocyte-like” (IMΦ) population were identified that demonstrated differential susceptibility to apoptosis. In wild-type mice, sepsis induced a 64% ± 7% and a 77% ± 3% decrease in absolute cell numbers of splenic DCs and IMΦ, respectively (n = 7, P < 0.05). Mature MΦ were not depleted in sepsis. No significant cell depletion was evident in Vav–Bcl-2, H-2K–Bcl-2, or Bim−/− mice. We conclude that sepsis induces a major depletion of developing MΦ as well as DCs, and this depletion may be an important mechanism of immune suppression in sepsis.

Keywords: Apoptosis, cytokine, cecal ligation and puncture

INTRODUCTION

Despite highly specialized delivery of intensive care, ~250,000 critically ill patients die of sepsis annually (13). Studies elucidating the mechanisms of this complex disease are essential for the development of a more effective therapy (4). Macrophages (MΦ) and dendritic cells (DCs) are key components of the innate immune system and are essential in orchestrating an effective host response. These cells present antigen to T cells and produce a myriad of cytokines that activate other effector cells (5). Dendritic cells are the most efficient antigen-presenting cells and can help direct the immune response to a proinflammatory or anti-inflammatory phenotype (6). Macrophages and immature DCs also engage in phagocytosis, thereby providing a frontline defense against microorganisms and ensuing efficient bacterial clearance. Yet, in sepsis, this response is severely impaired (68).

A key pathophysiological event in sepsis is the widespread apoptosis of immune effector cells. Studies by numerous independent laboratories have shown that sepsis induces profound apoptosis of CD4+ T cells and B220+ B cells (811). A great deal less is known regarding the fate of MΦ and DCs in sepsis because of the difficulty in distinguishing apoptotic MΦ and DCs from live cells that have ingested apoptotic cells. Therefore, many diagnostic tests for apoptosis have a high false-positive rate when applied to phagocytic cells because of the apoptotic debris that is present within these cells (9, 12). Despite these technical difficulties, several groups have reported that MΦ and selected subsets of DCs undergo apoptosis in sepsis (1315). Although numerous studies have characterized in vitro monocyte (MO) and MΦ dysfunction (13, 1619) during sepsis, few studies have examined the in vivo propensity of MΦ and DCs to undergo apoptosis.

The Bcl-2 family consists of both antiapoptotic and proapoptotic proteins that regulate cell survival in a number of pathological conditions including I/R injury, hypoxia, and toxin exposure. A number of studies demonstrated that overexpression of Bcl-2 prevented apoptotic cell death of lymphocytes during sepsis (2023). Ding et al. (14) have reported that myeloid-restricted overexpression of Bcl-2 only minimally protected splenic DCs (CD11b+) from sepsis-induced cell depletion. However, few studies have examined whether the deletion of proapoptotic or the overexpression of antiapoptotic proteins (hematopoietic cell or lymphocyte-restricted) prevents splenic MΦ or DC death in sepsis. In this study, we characterized the effect of sepsis on splenic MΦ and DCs and identified a potential mechanism for this cell loss. Based on known changes in gene expression and cellular function that occur with maturation, we hypothesized that different MΦ subsets may have distinct propensities to undergo sepsis-induced apoptosis. We evaluated the role of the Bcl-2 family members in sepsis-induced apoptosis using both transgenic and knockout animals. Cell loss was measured indirectly by determining absolute cell counts via flow cytometry. The intracellular expression of Bcl-2 and Bim was also examined to investigate whether significant changes in these death modulators correlated with cell loss and, ultimately, apoptosis. Finally, we evaluated the in vivo functional capacity of these cells to produce the multifunctional cytokine, IL-6, because several studies have reported that high IL-6 concentrations correlated with higher sepsis-induced mortality (24, 25).

MATERIALS AND METHODS

Mice

C57BL/6 mice (6 – 8 weeks old) were purchased from Jackson Laboratory (Bar Harbor, Me). Vav–Bcl-2 mice, which overexpress human Bcl-2 on all nucleated cells of hematopoietic tissue (controlled by the vav promoter), were kindly provided by Dr Jerry Adams (WEHI Institutes) (26). H-2K–Bcl-2 mice, which overexpress human Bcl-2 on all MHC class I cells (controlled by the H-2K promoter), were kindly provided by Dr Irving Weismann (Stanford University, Palo Alto, Calif) (27). Bim−/− mice were generated by Drs Philippe Bouillet and Andreas Strasser (28) (Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia) and were kindly provided by Dr David Holtzman (Washington University School of Medicine, St Louis, Mo). All transgenic and knockout male mice (6 – 8 weeks old) are on a C57/BL6 background and have been backcrossed for at least 10 generations. Each group of mice was compared with their respective age- and sex-matched controls. Wild-type (WT) littermates or WT “in-house” controls (C57/BL6 mice born and bred in the Washington University Animal Housing facility) were used as controls.

Polymicrobial intra-abdominal sepsis

Mice were housed for a minimum of 1 week before operation. The modified cecal ligation and puncture (CLP) model of polymicrobial intra-abdominal sepsis was used to examine sepsis-induced innate cell loss (29). Animals were prepared for surgery, abdominal hair was shaved, and povidone-iodine (Betadine) was applied to the area. Isoflurane-anesthetized animals underwent a 1-cm abdominal incision. The cecum was ligated below the ileocecal valve with 4–0 silk thread and punctured twice with a 27-gauge needle. Sham mice were treated in an identical fashion, but the cecum was neither ligated nor punctured. The abdomen was closed in two layers with both wound glue and 4–0 silk sutures. After surgery, the animals also received 1 mL of 0.9% saline/buprenorphine (Buprenex; 0.75 mg/kg) subcutaneously. They were allowed water and standard chow ad libitum. Animal experimentation and care were approved by the Animal Studies Committee at Washington University School of Medicine and were in accordance with the National Institute of Health animal guidelines.

Flow cytometric detection of different splenocyte populations—phenotype markers and forward- and side-scatter properties

To determine if the putative sepsis-induced loss in splenic DCs and MΦ was due to apoptosis, mice with selective overexpression of Bcl-2 or deletion of Bim were studied. Previous studies have shown that Bcl-2 overexpression or Bim deletion confers marked protection against sepsis-induced lymphocyte apoptosis (2023). Twenty hours after sham or CLP injury, WT, transgenic, and knockout spleens were harvested and ground between sterile frosted glass slides. Cells were washed and resuspended in 3 mL/spleen of RPMI-1640–10% fetal calf serum (supplemented with 500 ng/mL collagenase type 2 (Worthington Biochemicals, Freehold, NJ) and 0.02 µg/mL DNAse I (Sigma, St Louis, Mo) to break adherence and splenic stromal interactions and aid in optimal recovery of DCs and MΦ. Forty-five minutes after continuous shaking at 37°C, erythrocytes were lysed with hyptonic saline, and cells were washed with RPMI 1640–10% fetal calf serum. To diminish nonspecific binding of immunoglobulins to FcγIII and FcγII receptors, cells were incubated for 10 min with purified anti–mouse CD16/CD32 (e-Bioscience, San Diego, Calif). As previously described (30), the cells were then stained for 30 min in the dark with the following appropriate isotype controls and cocktails that were obtained from e-Bioscience unless otherwise noted and include fluorescein isothiocyanate, PE, PE-Cy5, PerCP5.5, APC, Alexa 750, and biotin cell surface markers: anti–mouse CD11b (clone M1/70), CD11c (clone N418), CD3 (clone 145-2C11), CD4 (clone RM4-5), CD8 (clone 53–6.7), CD19 (clone 1D3), CD45R/B220 (clone RA3-6B2), CD68 (clone FA-11; AbD Serotec), F480 (clone BM8), CD49b (clone DX5), Gr-1 (clone RB6-8C5), Ly6.C (clone HK1.4; Abcam, Cambridge, Mass), MHCII (clone M5/114.15.2; BD Pharmingen, San Jose, Calif), NK1.1 (clone PK136). Twenty hours after sham or CLP injury, splenic cell populations were identified via specific cell surface phenotypes. Characteristic forward- and side-scatter properties of different cell types, that is, lymphocytes, neutrophils, MΦ, or DCs were used as confirmatory indicators of cell subsets and to exclude dead cells.

Flow cytometry quantification of splenic cell loss

Cells were analyzed (100,000 – 150,000 events per sample) via FACScan flow cytometer (BD Biosciences, San Jose, Calif) (upgraded to five colors by Cytek, Freemont, Calif), which used both CELL Quest and Rainbow (Cytek) software for data acquisition. Flow Jo (TreeStar, Ashland, Ore) software was used to further analyze the data to quantitate cell loss. Forward- and side-scatter parameters were used to define specific cell populations (T and B lymphocytes, granulocytes, and natural killer cells) and eliminate those cell types from further analysis).

The decision not to use conventional markers of apoptosis, such as TUNEL, active caspase 3, propidium iodide, or annexin V, was warranted in our in vivo CLP model because phagocytic cells can stain false positive. Apoptotic cells ingested by MΦ can transfer their membrane to the surface. Thus, the MΦ can stain falsely positive for annexin V (9, 12). Because MΦ are highly phagocytic, which may cause them to stain falsely positive for TUNEL or active caspase 3, apoptosis was measured indirectly by a decrease in absolute cell counts. Total cell counts per spleen were determined via the Vi-Cell counter (Beckman Coulter), which was used as 100% for further calculation of subset populations of total cell counts. Flow cytometric analysis provided the percentages for the various splenic populations, that is, CD4+ T cells, CD11b+, F4/80+, MΦ, and so on. The cell counts for each splenic subset population were calculated using the following formula: cell counts of subpopulations = total cell counts [determined by Vi-Cell counter] × subset population percentage [determined by flow cytometer] / 100.

Determination of Bcl-2 and Bim expression in splenic MΦ

Wild-type cells were prepared and identified using fluorescently labeled surface markers as described above. Cells were permeabilized with 1× Perm Wash, washed, and stained with PE-labeled anti–Bcl-2 (e-Bioscience) overnight at 4°C. An additional group of cells was examined for Bim expression using a primary rabbit anti-Bim antibody and a PE-labeled donkey anti–rabbit secondary antibody (Cell Signaling Technology).

Intracellular cytokine production

The percentage of intracellular IL-6–positive cells was examined in vivo 6 h after the onset of sepsis (CLP). Mice underwent sham or CLP and, 90 min after operation, received brefeldin A (250 µg/500 µL) via i.v. injection (tail vein). The brefeldin A regimen was modified from Liu and Whitton (31), and the animals were given 500 µL instead of 400 µL of the 250-µg solution. Brefeldin A is a Golgi transport inhibitor that allows the accumulation of cytokines, which can be detected via flow cytometry. Approximately 6 h after brefeldin A injection, splenocytes were harvested. The cells were permeabilized and labeled with fluorescein isothiocyanate–anti-IL-6 (e-Bioscience) for 3 h at 4°C. The cells were washed with PBS and analyzed (150,000 – 300,000 events per sample) via a FacScan flow cytometer to determine intracellular mediator production.

Statistical analysis

Data are reported as the mean ± SEM. The Student t test was used in analyzing data involving only two groups and the one-way ANOVA with Tukey multiple-comparisons test was used to analyze data with more than two groups (nonparameteric) using GraphPad Prism version 4.02 for Windows (GraphPad Software, San Diego, Calif; www.graphpad.com). Significance was reported at P < 0.05.

RESULTS

Sepsis-induced differential MΦ cell loss from the spleen

Two distinct splenic MΦ populations (Fig. 1, A and B) were identified in WT sham and CLP-operated mice. Splenic MΦ were categorized as either immature MΦ (IMΦ) or mature MΦ (MMΦ) based on their expressions of CD11b and F4/80. F4/80 is expressed on mostly resident tissue MΦ in the red pulp of the spleen and is significantly lower on less mature precursors of tissue MΦ (32, 33). Although both MΦ populations stained positive for intracellular macrosialin (murine CD68, a heavily glycosylated transmembrane protein that is specifically expressed by tissue MΦ) (data not shown), they differed in CD11b and F4/80 cell surface expression. The less differentiated IMΦ stained CD11bhiF/480inter, whereas the well-differentiated MMΦ stained F/480hiCD11binter. The MΦ population stained positive for CD68, CD11b, and F4/80 and negative for CD11c, Gr-1, CD3, CD4, CD8, B220, and NK1.1, thereby confirming that these cells were in fact MΦ and not DCs, granulocytes, T cells, B cells, or natural killer cells. Interestingly, compared with WT sham mice, WT CLP mice exhibited a 77% ± 3% decrease in total cell counts in the IMΦ population (n = 8 – 14 animals per group, P < 0.05; Fig. 1E).

Fig. 1Fig. 1Fig. 1
Sepsis induces differential splenic cell loss. A and B, Representative dot plot of splenic populations identified in sham and CLP mice (n = 1 mouse per sham or CLP group). Two distinct MΦ populations, that is, a “mature” macrophage ...

Sepsis-induced DC loss from the spleen

A DC population was also identified that stained highly positive for both CD11c and MHCII (Fig. 1, C and D). Interestingly, compared with WT sham mice, WT CLP mice exhibited a 64% ± 7% decrease in total cell counts in the DC population (n = 8 – 14 animals per group, P < 0.05; Fig. 1E). In contrast to the findings in the IMΦ and DCs, the absolute cell counts of MMΦ were not significantly decreased in sepsis in any mouse model (Fig. 1E).

Bcl-2 overexpression prevented sepsis-induced IMΦ and DC depletion

To determine whether the depletion of IMΦ was indicative of apoptosis, the effects of overexpression of human Bcl-2 was investigated in both sham and CLP injury in mice whose cells had selected overexpression of antiapoptotic proteins. Interestingly, overexpression of human Bcl-2 broadly in all hematopoietic-derived cells (Vav–Bcl-2 mice) and on all MHC class I cells (H-2K–Bcl-2 mice) did confer protection during sepsis to the splenic IMΦ population. IMΦ from Vav–Bcl-2 septic mice exhibited 14% ± 12% cell loss compared with the 76% ± 9% IMΦ loss in the WT septic mice (Fig. 2A). Similar to the septic Vav–Bcl-2 mice, septic H-2K–Bcl-2 mice conferred protection upon the IMΦ population, and minimal cell loss occurred (n = 3 – 6 per group, P < 0.05; Fig. 2B). Similar to the protection exhibited in the IMΦ population during sepsis, the DC population exhibited minimal depletion in septic Vav–Bcl-2 mice compared with septic WT mice. Dendritic cells from Vav–Bcl-2 septic mice exhibited only a 6% + 2% cell loss compared with the WT septic mice that exhibited a pronounced 72% + 6% cell loss (n = 3 – 6 per group, P < 0.05; Fig. 2A).

Fig. 2Fig. 2
Overexpression of human Bcl-2 attenuates sepsis-induced cell loss. Both septic Vav–Bcl-2 (A) and H-2K–Bcl–2 (B) mice exhibited significantly less total cell loss in the IMΦ and DC populations compared with septic WT mice. ...

Bim−/− mice exhibited significantly less sepsis-induced total cell loss in the splenic IMΦ and DC population

To confirm that IMΦ and DC cell loss was secondary to apoptosis, a second apoptotic strategy using Bim null mice was used. Wild-type sham and Bim−/− sham mice did not display depletion in either the splenic IMΦ or the DC population. The sepsis-induced depletion of IMΦ and DCs in WT mice was attenuated in septic Bim−/− mice. Only 22% ± 2% of IMΦ in septic Bim−/− mice were lost compared with 62% ± 8% in the septic WT mice. Similarly, DCs in septic Bim−/− mice showed an 11% ± 5% loss compared with a 58% ± 3% loss in septic WT animals (n = 8 – 14 per group, P < 0.05; Fig. 3).

Fig. 3
Bim−/− mice exhibit attenuated sepsis-induced total cell loss. Minimal IMΦ and DC total cell loss was exhibited in the septic Bim−/− mice compared with the septic WT mice. *P < 0.05 vs. corresponding sham ...

The expression of Bcl-2 was significantly decreased whereas Bim was increased in septic splenic IMΦ

To determine potential mechanism or pathways responsible for cell depletion during sepsis, intracellular content of Bcl-2 and Bim was examined in MΦ. The ratio of Bcl-2 to Bim has been shown to be a critical factor in cell survival (34, 35). Previous results from our laboratory have shown that lymphocytes that overexpressed Bcl-2 or have a deletion of Bim are resistant to sepsis-induced apoptosis (22, 36). Our data show that overexpression of Bcl-2 or deletion of Bim prevented IMΦ and DC cell loss during sepsis. We sought to determine if differences in Bcl-2 and Bim expression may be involved in the different sensitivity to undergo apoptosis exhibited by these two cell populations. We analyzed intracellular expression of Bcl-2 and Bim in the two MΦ populations in WT mice. Septic IMΦ exhibited a significant reduction in Bcl-2 expression (mean fluorescence intensity) compared with MMΦ (22 ± 4 vs. 67 ± 7, n = 7 per group, P < 0.05), respectively (Fig. 4A). Conversely, sepsis did not cause a significant difference in Bim expression between the IMΦ and MΦ populations (43 ± 9 vs. 38 ± 14, n = 7 per group, P < 0.05), respectively (Fig. 4B).

Fig. 4Fig. 4
Differential Bcl-2 and Bim expression is exhibited in the splenic MΦ. Intracellular Bcl-2 and Bim (MFI) expression was examined in MMΦ and IMΦ populations obtained from sham and septic animals. A, Intracellular Bcl-2 (MFI) expression ...

The ratio of Bcl-2 to Bim expression in WT sham animals was not significantly different between the IMΦ and MMΦ (2.1 ± 0.2 vs. 2.3 ± 0.1). Not surprising, in septic WT mice, the ratio of Bcl-2 to Bim was significantly decreased in the IMΦ compared with the MMΦ, 0.5 ± 0.1 vs. 1.7 ± 0.3, respectively (n = 7 per group, P < 0.05).

Differential in vivo intracellular IL-6 mediator production

Studies have implicated IL-6 production as a predictor of sepsis-induced mortality in the CLP model of sepsis (24, 25). To characterize potential differences in the two MΦ subtypes in regard to cytokine production, we analyzed the percentage of cells obtained from sham or septic mice that stained positive for IL-6. Ninety minutes after sham or CLP injury, mice received brefeldin A via i.v. injection. Brefeldin A prevents Golgi transport, thus inducing the accumulation of intracellular cytokines, which can be detected by flow cytometry (31). Six hours later, minimal to no intracellular IL-6–producing cells were seen in sham mice. In contrast, in CLP mice, 34% ± 4% of MMΦ and 16% ± 2% of IMΦ were IL-6–positive (n = 6, P < 0.05; Fig. 5).

Fig. 5Fig. 5Fig. 5
Flow cytometry analysis of in vivo intracellular IL-6 expression in splenic MΦ from WT mice that underwent sham or CLP injury. In the CLP group, a higher percentage of both MMΦ and IMΦ expressed IL-6 compared with sham. Overall, ...

DISCUSSION

Previous studies have shown that systemic apoptosis occurs diffusely in lymphoid tissue and correlates with sepsis-induced morbidity and mortality (9, 10). Few studies have examined whether MΦ undergo programmed cell death in sepsis because of difficulties in the specificity of the apoptotic assays in these phagocytic cells. Macrophages that have engulfed apoptotic cells will be falsely positive when evaluated by most tests for apoptosis. Consequently, we elected to evaluate apoptosis by quantifying absolute cell counts in WT mice and mice resistant to apoptosis because of modulation of the Bcl-2 family. The current study demonstrates that sepsis also induced depletion of a selective subset of splenic MΦ and DCs. The fact that IMΦ and DC depletion was inhibited by overexpression of the antiapoptotic protein, Bcl-2, or deletion of the proapoptotic protein, Bim, strongly supports the contention that the cells that were being lost were dying of apoptosis. The splenic MΦ population is heterogeneous. Developmental, functional, and phenotypic differences exist among the diverse MΦ population and may, in part, be responsible for the differential cell loss and in vivo cytokine production demonstrated in the IMΦ versus the more differentiated MMΦ noted in the present study (3739). Loss of the IMΦ and DC populations may have important consequences on host immune function and may contribute to impaired bacterial phagocytosis and clearance. This loss of MΦ and DCs will also have detrimental effects on efficient antigen presentation to lymphocytes (40).

One of the interesting findings in the present study is the differential susceptibility of the IMΦ versus the MMΦ to undergo apoptosis. Unlike the MMΦ that were resistant to cell loss, IMΦ exhibited a marked decrease in absolute cell counts at 20 h after the onset of sepsis. The present study demonstrates for the first time that, in the CLP model of sepsis, there was a significant decrease in absolute cell counts of splenic IMΦ (CD11bhigh/F480inter), whereas the highly differentiated MMΦ (F480high/CD11binter) were unaffected. The data suggest that sepsis induced differential cellular apoptosis in MΦ. We also demonstrated that splenic DCs (CD11chigh/MHCIIhigh) underwent sepsis-induced depletion. It has been reported that sepsis induced a significant decrease in the percentage of DCs that stain single positive for CD11c but not DCs that stain double positive for CD11c and MHCII (14). This discrepancy may be due to differences in the mouse strain, CLP injury, DC harvest methodology, and/or flow cytometry cell-gating strategies.

Several antiapoptotic and proapoptotic protein transgenic and knockout mouse models have been established and shown to abolish sepsis-induced lymphocyte apoptosis (20, 36, 41). The present study extends these findings by demonstrating that modulation of antiapoptotic and proapoptotic Bcl-2 family members prevents sepsis-induced loss of MΦ and DCs as well. Sepsis-induced depletion of splenic IMΦ was attenuated by overexpression of the human antiapoptotic protein Bcl-2 on all nucleated cells of hematopoietic tissues (Vav–Bcl-2 mice) and all MHC class I cells (H-2K–Bcl-2 mice).

The vulnerability of cells to undergo apoptosis has been reported to be dependent on the ratio of antiapoptotic versus proapoptotic Bcl-2 family members (34, 35). Given previous work from the laboratory demonstrating the key roles of Bcl-2 and Bim in sepsis-induced apoptosis, we examined the Bcl-2/Bim ratio as an index of apoptotic propensity. In the septic IMΦ population, there was a marked decrease in intracellular antiapoptotic Bcl-2 expression coupled with a significant increase in intracellular proapoptotic Bim expression. Importantly, the Bcl-2/Bim ratio was significantly decreased in the IMΦ compared with the MMΦ population, and this finding is consistent with the increased cell loss in the former compared with the latter. Along the same lines, it has been reported that staphylococcal enterotoxin A–activated T cells undergoing apoptosis exhibited a ~50% decrease in their expression of Bcl-2 compared with resting T cells (42, 43). Furthermore, our studies showing decreased IMΦ Bcl-2 concentration are consistent with the data by Adrie et al. (44), who noted that blood MOs from septic nonsurvivors exhibit significantly less intracellular Bcl-2 expression compared with septic survivors.

Finally, the data demonstrating differential susceptibility to apoptosis in IMΦ versus MMΦ are paralleled by studies in differentiated MOs. Perlman et al. (45) have reported that, during MO differentiation into MΦ, the expression of FLICE-inhibitory protein (Flip) prevented the activation of Fas-mediated apoptosis in MΦ. Thus, highly differentiated MΦ were more resistant to apoptosis than the less differentiated MO. The present data demonstrate that immune effector cells from the Bcl-2 transgenic and Bim null mice are not lost in sepsis. This finding establishes that cell depletion in sepsis is secondary to programmed cell death and suggests potential therapeutic implications. Previous work from Wesche-Soldato et al. (46) as well as that from our group (47) has shown that siRNAs directed against the caspase family or the proapoptotic Bcl-2 family members prevented apoptotic death and improved survival in sepsis. Macrophages and DCs are able to “take up” siRNAs, and thus, anti-Bim siRNA therapy may be one method to prevent loss of these critical cells during sepsis.

The splenic MΦ populations differed not only in their phenotypic cell surface marker expression, Bcl-2/Bim ratios, and propensity to undergo sepsis-induced apoptosis, but also in their capacity to produce IL-6. The ability to investigate in vivo intracellular mediator production allows one to detect tissue cell-specific cytokine responses. Because MΦ are a major source of IL-6, we investigated the effects of sepsis on MΦ production of IL-6. The 6-h time point was examined because the absolute cell counts of the splenic IMΦ population are comparable between both sham and CLP animals. IL-6 elicits both proinflammatory and anti-inflammatory responses (48) and is upregulated in the plasma for up to 24 h after CLP (25). In vivo, 6 h after the onset of sepsis, a significantly higher percentage of MMΦ (34% ± 4%) was IL-6–positive compared with the percentage of IMΦ (16% ± 2%). However, the former has an inherently higher IL-6–producing capacity. The differential production of IL-6 may in part be due to the maturation of the populations and the efficiency of downstream IL-6 receptor signaling. It may be of relevance to further characterize mediator production in both MΦ subsets during the progression of sepsis.

In summary, sepsis-induced extensive depletion of IMΦ and DCs and the loss in these important immune effector cells may seriously impair host antimicrobial defenses. The ability to prevent cell loss through the modulation of Bcl-2 family members such as overexpression of antiapoptotic proteins or deletion of proapoptotic proteins suggests that these cell populations undergo sepsis-induced apoptosis in vivo. The decreased Bcl-2/Bim ratio may be an important mechanism of sepsis-induced depletion of IMΦ. Antiapoptotic therapies targeting these cell populations may marshal the host response and decrease sepsis-induced morbidity and mortality.

ACKNOWLEDGMENTS

This work was supported by the National Institutes of Health grants GM44118, GM055194, and GM055194-10S1 and the Alan A. and Edith L. Wolff Foundation.

The authors thank the staff at Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, MO, for the use of the High Speed Cell Sorter Core, which provided flow cytometry service. The Siteman Cancer Center is supported in part by a NCI Cancer Center support grant no. P30 CA91842.

Footnotes

Manuscript was selected as one of the finalists for the Young Investigator Award at the 2008 International Shock Society Meeting in Cologne, Germany.

REFERENCES

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310. [PubMed]
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554. [PubMed]
3. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis form 1993 to 2003. Crit Care Med. 2007;35:1244–1250. [PubMed]
4. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327. [PubMed]
5. Maier RV. The angry macrophage and its impact on host response mechanisms. In: Faist E, Meakins J, Schildberg FW, editors. Host Defense Dysfunction in Trauma, Shock, and Sepsis. Heidelberg, Germany: Springer-Verlag; 1993. pp. 19–197.
6. Efron PA, Moldawer LL. Sepsis and the dendritic cell. Shock. 2003;20:386–401. [PubMed]
7. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–150. [PubMed]
8. Ayala A, Herdon DC, Lehman DL, Ayala CA, Chaudry IH. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency and the nature of the mediators. Blood. 1996;87:4261–4275. [PubMed]
9. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001;166:6952–6963. [PubMed]
10. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med. 1999;27:1230–1251. [PubMed]
11. Efron PA, Tinsley K, Minnich DJ, Monterroso V, Wagner J, Lainee P, Lorre K, Swanson PE, Hotchkiss RS, Moldawer LL. Increased lymphoid tissue apoptosis in baboons with bacteremic shock. Shock. 2004;21:566–571. [PubMed]
12. Moraes TJ, Downey GP. Death of the septic monocyte: is more better? Crit Care. 2006;10:146–147. [PMC free article] [PubMed]
13. Ayala A, Urbanich MA, Herdon CD, Chaudry IH. Is sepsis-induced apoptosis associated with macrophage dysfunction. Trauma. 1996;40:568–574. [PubMed]
14. Ding T, Chung C, Newton S, Chen Y, Carlton S, Albina JE, Ayala A. Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock. 2004;22:137–144. [PMC free article] [PubMed]
15. Lu MC, Liu TA, Lee MR, Lin L, Chang WC. Apoptosis contributes to the decrement in numbers of alveolar macrophages from rats with polymicrobial sepsis. J Microbiol Immunol Infect. 2002;35:71–77. [PubMed]
16. Chung C, Song GY, Lomas J, Simms HH, Chaudry IH, Ayala A. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol. 2003;74:344–351. [PubMed]
17. Ellaban E, Bolgos G, Remick DG. Selective macrophage suppression during sepsis. Cell Immunol. 2004;231:103–111. [PubMed]
18. Peck OM, Fan H, Tempel G, Teti G, Halushka P, Cook JA. Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-γ Shock. 2004;21:254–260. [PubMed]
19. Peck OM, Williams D, Breuel K, Kalbfleisch J, Fan H, Tempel G, Teti GJ, Cook JA. Differential regulation of cytokine and chemokine production in lipopolysaccharide induced tolerance and priming. Cytokine. 2004;26:202–208. [PubMed]
20. Iwata A, Stevenson VM, Minard A, Tasch M, Tupper J, Lagasse E, Weissman I, Harlan JM, Winn RK. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol. 2003;171:3136–3141. [PubMed]
21. Oberholzer C, Oberholzer A, Bahjat FR, Minter RM, Tannahill CL, Abouhamze A, LaFace D, Hutchins B, Clare-Salzer MJ, Moldawer LL. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. 2001;98:11503–11508. [PubMed]
22. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, Zollner KM, Buchman TG, Korsmeyer SJ, Karl IE. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol. 1999;162:4148–4156. [PubMed]
23. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, Korsmeyer SJ, Karl IE. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci. 1999;96:14541–14546. [PubMed]
24. Ebong SJ, Call DR, Bolgos G, Newcomb DE, Granger JI, O'Reilly M, Remick DG. Immunopathologic responses to non-lethal sepsis. Shock. 1999;12:118–126. [PubMed]
25. Remick DG, Bolgos G, Siddiqui J, Shin J, Nemzek J. Six at six: interleukin-6 measured 6H after the initiation of sepsis predicts mortality over 3 days. Shock. 2002;17:463–467. [PubMed]
26. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci. 1999;96:14943–14948. [PubMed]
27. Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med. 2000;191:253–264. [PMC free article] [PubMed]
28. Bouillet P, Metcalf D, Huang DCS, Tarlinton DM, Kay TWH, Kontgen F, Adams JM, Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 1999;286:1735–1738. [PubMed]
29. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983;94:331–335. [PubMed]
30. Peck Palmer O, Unsinger J, Chang KC, Davis C, McDunn J, Hotchkiss RS. Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival. J Leukoc Biol. 2008;83:1009–1018. [PubMed]
31. Liu F, Whitton JL. Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J Immunol. 2005;174:5936–5940. [PubMed]
32. Gordon S, Lawson L, Rabinowitz S, Crocker PR, Morris L, Perry VH. Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol. 1992;181:1–37. [PubMed]
33. McKnight AJ, Gordon S. Membrane molecules as differentiation antigens of murine macrophages. Adv Immunol. 1998;68:271–314. [PubMed]
34. Korsmeyer SJ. Regulators of cell death. Trends Genet. 1995:101–105. [PubMed]
35. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47–59. [PubMed]
36. Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, Strasser A, Hotchkiss RS. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J. 2007;21:708–719. [PubMed]
37. Lagasse E, Weissman IL. Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods. 1996;197:139–150. [PubMed]
38. Witmer MD, Steinman RM. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch. Am J Anat. 1984;170:465–481. [PubMed]
39. Newton S, Ding Y, Chung C, Chen Y, Lomas-Neira JL, Ayala A. Sepsis-induced changes in macrophage co-stimulatory molecule expression CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect. 2004;5:375–383. [PMC free article] [PubMed]
40. Liu YJ. Dendritic cell subsets and lineages and their functions in innate and adaptive immunity. Cell. 2001;106:259–262. [PubMed]
41. Wagner TH, Drewry AM, MacMillan S, Dunne WM, Chang KC, Karl IE, Hotchkiss RS, Cobb JP. Surviving sepsis: bcl-2 overexpression modulates splenocyte transcriptional responses in vivo. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1751–R1759. [PubMed]
42. Mitchell T, Kappler J, Marrack P. Bystander virus prolongs activated T cell survival. J Immunol. 1999;162:4527–4535. [PubMed]
43. Jorgensen TN, McKee A, Wang M, Kushnir E, White J, Refaeli Y, Kappler JW, Marrack P. Vim and Bcl-2 mutually affect the expression of the other in T cells. J Immunol. 2007;179:3417–3424. [PubMed]
44. Adrie C, Bachelet M, Vayssier-Taussat M, Russo-Marie F, Bouchaert I, Adib-Conquy M, Cavaillon J, Pinsky M, Dhainaut J, Polla B. Mitochondrial membrane potential and apoptosis in peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med. 2001;164:389–395. [PubMed]
45. Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis. J of Exp Med. 1999;190:1679–1688. [PMC free article] [PubMed]
46. Wesche-Soldato DE, Chung CS, Lomas-Neira J, Doughty LA, Gregory SH, Ayala A. In vivo delivery of caspase 8 or Fas siRNA improves the survival of septic mice. Blood. 2005;106:2295–2301. [PubMed]
47. Schwulst S, Munser J, Peck Palmer O, Unsinger J, Chang KC, McDunn J, Hotchkiss RS. Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis. Shock. 2008 E-pub ahead of print. [PubMed]
48. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994;83:113–118. [PubMed]